• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Catalog Number ZIV6-35-125-6.0-120-PTX
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stenosis (2263); Claudication (2550)
Event Date 08/18/2015
Event Type  Injury  
Manufacturer Narrative
Pma/510(k)#: p100022/s001.The ziv6-35-125-6.0-120-ptx stent of lot number c775583 was implanted in the patient, therefore is not available for evaluation.With the information provided a document based investigation was carried out.It was confirmed that images would not be available to support the complaint investigation.According to complaint information provided, intermittent claudication and worsen rutherford were observed on the patient.It can be noted that these symptoms indicate progression of peripheral artery disease and can also be associated with the restenosis process.Restenosis is a common adverse event of endovascular procedures and can be caused by injury to the vessel (e.G.During pta and/or stenting).Vessel injury provokes an inflammatory response that leads to (or amplifies) the restenosis process.It may be noted that the surface of the zilver ptx stent is coated with the drug paclitaxel to help prevent subsequent restenosis of the artery.It can be therefore stated that it is very unlikely that the reported restenosis could have occurred due to zilver ptx malfunction; however a definitive cause of this event cannot be determined.Due to lack of imaging no other comments can be made.There is no evidence to suggest that this event did not occur, therefore the complaint is confirmed based on customer testimony.It may be noted that restenosis of the stented artery is a known potential adverse event associated with placement of this device.Prior to distribution all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.A review of the relevant manufacturing records revealed no discrepancies that could have contributed to this complaint.According to information provided pta was performed and no other adverse events were reported for the patient.Quality engineering will continue to monitor complaints of this nature for potential emerging trends.
 
Event Description
On (b)(6) 2012: two ziv6-35-125-6.0-120-ptx were placed in the patient's right lower sfa.On (b)(6) 2012: ziv6-35-125-6.0-60-ptx was placed in the patient's right upper sfa.On (b)(6) 2015: restenosis (100%) where the ptx were placed (right upper and lower sfa) was confirmed.Intermittent claudication and worsen rutherford were seen on the patient.Pta performed.As three zilver ptx devices are reported to be involved in this event, three separate reports have been submitted for each suspect device.Reference also reports 3001845648-2015-00315 and 3001845648-2015-00316.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
Type of Device
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer Contact
sinead quaid
o'halloran road
national technology park
limerick 
061334440
MDR Report Key5334162
MDR Text Key34648966
Report Number3001845648-2015-00314
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
PMA/PMN Number
P100022
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 12/04/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/30/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberZIV6-35-125-6.0-120-PTX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date08/18/2015
Event Location Hospital
Date Manufacturer Received12/04/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/11/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age78 YR
-
-